These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28635257)

  • 1. Circular Bivalent Aptamers Enable in Vivo Stability and Recognition.
    Kuai H; Zhao Z; Mo L; Liu H; Hu X; Fu T; Zhang X; Tan W
    J Am Chem Soc; 2017 Jul; 139(27):9128-9131. PubMed ID: 28635257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Engineering of Aptamer Self-Assemblies Increases
    Xia F; He A; Zhao H; Sun Y; Duan Q; Abbas SJ; Liu J; Xiao Z; Tan W
    ACS Nano; 2022 Jan; 16(1):169-179. PubMed ID: 34935348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability Is Not Everything: The Case of the Cyclisation of a Thrombin-Binding Aptamer.
    Riccardi C; Meyer A; Vasseur JJ; Russo Krauss I; Paduano L; Oliva R; Petraccone L; Morvan F; Montesarchio D
    Chembiochem; 2019 Jul; 20(14):1789-1794. PubMed ID: 30860635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
    Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.
    Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simple, pH-Activatable Fluorescent Aptamer Probe with Ultralow Background for Bispecific Tumor Imaging.
    Shi H; Lei Y; Ge J; He X; Cui W; Ye X; Liu J; Wang K
    Anal Chem; 2019 Jul; 91(14):9154-9160. PubMed ID: 31185714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybridization-based aptamer labeling using complementary oligonucleotide platform for PET and optical imaging.
    Park JY; Lee TS; Song IH; Cho YL; Chae JR; Yun M; Kang H; Lee JH; Lim JH; Cho WG; Kang WJ
    Biomaterials; 2016 Sep; 100():143-51. PubMed ID: 27258484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular L-RNA aptamer promotes target recognition and controls gene activity.
    Ji D; Lyu K; Zhao H; Kwok CK
    Nucleic Acids Res; 2021 Jul; 49(13):7280-7291. PubMed ID: 34233000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer.
    Filippi L; Bagni O; Nervi C
    Expert Rev Med Devices; 2020 Aug; 17(8):751-758. PubMed ID: 32669004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Tumor Accumulation of Aptamers by Prolonged Blood Circulation.
    Ding D; Yang C; Lv C; Li J; Tan W
    Anal Chem; 2020 Mar; 92(5):4108-4114. PubMed ID: 32037790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity improvement of a VEGF aptamer by in silico maturation for a sensitive VEGF-detection system.
    Nonaka Y; Yoshida W; Abe K; Ferri S; Schulze H; Bachmann TT; Ikebukuro K
    Anal Chem; 2013 Jan; 85(2):1132-7. PubMed ID: 23237717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature-Inspired Smart DNA Nanodoctor for Activatable In Vivo Cancer Imaging and In Situ Drug Release Based on Recognition-Triggered Assembly of Split Aptamer.
    Lei Y; Tang J; Shi H; Ye X; He X; Xu F; Yan L; Qiao Z; Wang K
    Anal Chem; 2016 Dec; 88(23):11699-11706. PubMed ID: 27807977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
    Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
    Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assays for aptamer-based platforms.
    Citartan M; Gopinath SC; Tominaga J; Tan SC; Tang TH
    Biosens Bioelectron; 2012 Apr; 34(1):1-11. PubMed ID: 22326894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the Substrate Selectivity of DNA Aptamers Using Surfactants.
    Peterson AM; Jahnke FM; Heemstra JM
    Langmuir; 2015 Nov; 31(43):11769-73. PubMed ID: 26465173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting by an aptamer.
    Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
    J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.